The Anti-CD38 Monoclonal Antibody TAK-079 Depletes Antibody Secreting Cells from Normal and SLE Patients

被引：0
|
作者：
Wang, Xiaoqian [1 ,2 ]
Dahl, Martin [3 ]
Nguyen, Doan [4 ]
Jenks, Scott [1 ,2 ]
Cashman, Kevin [1 ,2 ]
Lee, F. Eun-Hyung [5 ]
McLean, Lachy [6 ]
Sanz, Ignacio [2 ,7 ]
机构：
[1] Emory Univ, Sch Med, Div Rheumatol, Atlanta, GA USA
[2] Emory Univ, Sch Med, Lowance Ctr Human Immunol, Atlanta, GA USA
[3] Tekada Pharmaceut, San Diego, CA USA
[4] Emory Univ, Sch Med, Atlanta, GA USA
[5] Emory Univ, Sch Med, Med, Atlanta, GA USA
[6] Takeda Global Res & Dev Ctr Inc, San Diego, CA USA
[7] Emory Univ, Sch Med, Rheumatol, Atlanta, GA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1085
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing
    Ehrend, Elisabeth
    Manns, Patricia
    Harenkamp, Sabine
    Seifried, Erhard
    Geisen, Christof
    Bonig, Halvard
    BLOOD, 2021, 138 (09) : 814 - 817
  • [42] Hepatitis B reactivation in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based therapies: a pharmacovigilance analysis
    Donald C. Moore
    Joseph B. Elmes
    Justin R. Arnall
    Scott A. Strassels
    Jai N. Patel
    International Journal of Clinical Pharmacy, 2023, 45 : 1492 - 1495
  • [43] Treatment patterns and clinical outcomes in multiple myeloma patients previously treated with lenalidomide and an anti-CD38 monoclonal antibody: findings from the PREAMBLE registry
    Goldschmidt, Hartmut
    Vij, Ravi
    Kuter, David
    Cella, David
    Moreau, Philippe
    Durie, Brian
    Petrucci, Maria-Teresa
    Tang, Yuexin
    Dhanasiri, Sujith
    Gu, Jin
    Fish, Susan
    Ramasamy, Karthik
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S180 - S181
  • [44] Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma
    Quach, Hang
    Benson, Simon
    Haysom, Helen
    Wilkes, Anne-Marie
    Zacher, Nicole
    Cole-Sinclair, Merrole
    Prince, Henry Miles
    Mollee, Peter
    Spencer, Andrew
    Ho, Phoebe Joy
    Harrison, Simon J.
    Lee, Cindy
    Augustson, Bradley
    Daly, James
    INTERNAL MEDICINE JOURNAL, 2018, 48 (02) : 210 - 220
  • [45] Hepatitis B reactivation in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based therapies: a pharmacovigilance analysis
    Moore, Donald C. C.
    Elmes, Joseph B. B.
    Arnall, Justin R. R.
    Strassels, Scott A. A.
    Patel, Jai N. N.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (06) : 1492 - 1495
  • [46] Impact of monoclonal anti-CD38 antibody on collected myeloid and erythroid progenitor cells and clinical course of autologous stem cell transplant for patients with multiple myeloma
    Manjappa, Shivaprasad
    Eduafo, Augusta
    Fox, Robert
    Reese, Jane
    Schmikla, Hannah
    Kolk, Merle
    Driscoll, James
    Malek, Ehsan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S50 - S50
  • [47] Pre-Clinical Efficacy of the Anti-CD38 Monoclonal Antibody (mAb) Isatuximab in Acute Myeloid Leukemia (AML)
    Jelinek, Tomas
    Zabaleta, Aintzane
    Perez, Cristina
    Ajona, Daniel
    Alignani, Diego
    Rodriguez, Idoia
    Garate, Sonia
    Sarvide, Sarai
    Lasa, Marta
    Maiso, Patricia
    Prosper, Felipe
    Hajek, Roman
    San Miguel, Jesus F.
    Paiva, Bruno
    BLOOD, 2017, 130
  • [48] Daratumumab, a Novel Potent Human Anti-CD38 Monoclonal Antibody, Induces Significant Killing of Human Multiple Myeloma Cells: Therapeutic Implication
    Tai, Yu-Tzu
    de Weers, Michel
    Li, Xian-Feng
    Song, Weihua
    Nahar, Sabikun
    Bakker, Joost M.
    Vink, Tom
    Jacobs, Danielle
    Oomen, Lukas
    Bleeker, Wim K.
    Munshi, Nikhil C.
    van de Winkel, Jan G. J.
    Parren, Paul W. H. I.
    Richardson, Paul
    Anderson, Kenneth C.
    BLOOD, 2009, 114 (22) : 252 - 252
  • [49] Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment
    Motais, Benjamin
    Charvatova, Sandra
    Walek, Zuzana
    Hrdinka, Matous
    Smolarczyk, Ryszard
    Cichon, Tomasz
    Czapla, Justyna
    Giebel, Sebastian
    Simicek, Michal
    Jelinek, Tomas
    Sevcikova, Tereza
    Sobotka, Jiri
    Koristek, Zdenek
    Hajek, Roman
    Bago, Juli R.
    CELLS, 2021, 10 (05)
  • [50] Anti-CD38 Monoclonals for Treatment of Antibody-mediated Rejection in Renal Allografts
    Jordan, Stanley C.
    TRANSPLANTATION, 2025, 109 (02) : 228 - 230
12345